NASDAQ: MRKRMarker Therapeutics Inc Stock Ownership - Who owns Marker Therapeutics?
Insider buying vs selling
Have Marker Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when MRKR insiders and whales buy or sell their stock.
MRKR Shareholders
What type of owners hold Marker Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Anthony A. Florence Jr. | 120.35% | 10,714,285 | $47.14M | Insider |
| New Enterprise Associates 16 LP | 120.35% | 10,714,285 | $47.14M | Insider |
| Carmen Chang | 120.35% | 10,714,285 | $47.14M | Insider |
| Joshua Makower | 120.35% | 10,714,285 | $47.14M | Insider |
| Paul Edward Walker | 120.35% | 10,714,285 | $47.14M | Insider |
| Scott D. Sandell | 120.35% | 10,714,285 | $47.14M | Insider |
| Ali Behbahani | 120.35% | 10,714,285 | $47.14M | Insider |
| Peter W. Sonsini | 120.35% | 10,714,285 | $47.14M | Insider |
| Mohamad Makhzoumi | 120.35% | 10,714,285 | $47.14M | Insider |
| Forest Baskett | 120.35% | 10,714,285 | $47.14M | Insider |
MRKR vs Biotech Stocks
Marker Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.